The hits keep coming: Biogen’s Aduhelm marketing, approval under fire in new FTC and SEC probes
The hits keep coming: Biogen’s Aduhelm marketing, approval under fire [...]
Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid patent cliff looms
Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid [...]
UPDATED: Sanofi’s flu shots took a back seat to COVID-19 boosters late last year, and major job cuts still loom
UPDATED: Sanofi’s flu shots took a back seat to COVID-19 [...]
Sanofi’s Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter
Sanofi’s Dupixent rolls on, but US flu shots took backseat [...]
Eli Lilly’s Trulicity dethrones Dupixent, taking January’s TV ad spending crown
Eli Lilly’s Trulicity dethrones Dupixent, taking January’s TV ad spending [...]
Fierce Pharma Asia—AstraZeneca China’s fraud investigation; Women promoted at Takeda; Samsung buy of Biogen’s stake in biosimilar JV
Fierce Pharma Asia—AstraZeneca China’s fraud investigation; Women promoted at Takeda; [...]
Sanofi launches new corporate brand and logo, and that goes for Genzyme and Sanofi Pasteur, too
Sanofi launches new corporate brand and logo, and that goes [...]
Roche revs up new launches—and a slew of data readouts—as it emerges from the biosim trough
Roche revs up new launches—and a slew of data readouts—as [...]
Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations
Humira rings up $20.7B in 2021, but AbbVie still mum [...]
DHL earmarks $400M to expand its pharma, medical device supply chain network this year
DHL earmarks $400M to expand its pharma, medical device supply [...]